The impact of donor hepatitis B virus infection on transplant outcomes in deceased donor kidney transplantation recipients.

ABSTRACT:

Background

The use of hepatitis B virus (HBV)-positive donor kidneys to expand the donor pool has been implemented, but limited evidence exists regarding their impact on transplant outcomes. This study aimed to investigate the effects of donor HBV infection on transplant outcomes.

Methods

Donor and recipient data between 2015 and 2021 were collected. A total of 743 kidney transplant cases were screened, including 94 donor hepatitis B surface antigen (HBsAg)+/recipient HBsAg- (D+R-) and 649 donor HBsAg-/recipient HBsAg- (D-R-) cases. The analysis endpoints included recipient HBV infection, delayed graft function (DGF), peak estimated glomerular filtration rate (eGFR) within 12 months, recipient survival, and death-censored graft survival (DCGS).

Results

The D+R- group

SUBMITTER: Luo Y 

PROVIDER: S-EPMC11985285 | biostudies-literature | 2025 Mar

REPOSITORIES: biostudies-literature